Clinical Trial Detail

NCT ID NCT03389230
Title Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors City of Hope Medical Center
Indications

malignant glioma

Therapies

HER2 CAR-T cells

Age Groups: adult senior

Additional content available in CKB BOOST